RxDoctor Payments Data

Jeana Garris, PA

Physician Assistant · Houston, TXNPI 1104096478

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Boehringer Ingelheim accounts for 68.0% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $7,741, more than ten times the $185 reported in 2021. Among physician assistant clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,380in general payments, 2019–2025

Across 45 payments — averaging $252.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$8K
  • Exelixis Inc.$3K
  • Incyte Corporation$108
  • Takeda Pharmaceuticals U.S.A., Inc.$30
  • Sanofi$25
  • Optinose US, Inc.$22

What the payments were for

  • Consulting fees$4,27538%
  • Speaking & faculty fees$8057%
  • Travel & lodging$4,45439%
  • Food & beverage$1,84616%

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,380 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas →

Medicare billing

Part B allowed, 2024
$10,638
Medicare patients
99
Services billed
127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase19$30,074
Ondansetron Hcl11$69

Paid to pharmacies, not to this prescriber.

Other physician assistant in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →